Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population.
Nasrallah GK, Dargham SR, Shurrab F, Al-Sadeq DW, Al-Jighefee H, Chemaitelly H, Al Kanaani Z, Al Khal A, Al Kuwari E, Coyle P, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Rahim HFA, Yassine HM, Al Kuwari MG, Qotba H, Al Romaihi HE, Tang P, Bertollini R, Al-Thani MH, Althani AA, Abu-Raddad LJ.
Nasrallah GK, et al. Among authors: qotba h.
Sci Rep. 2021 Jun 4;11(1):11837. doi: 10.1038/s41598-021-91235-x.
Sci Rep. 2021.
PMID: 34088944
Free PMC article.